Dosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism

Affiliations

Comment

Mary T Thanh Hai et al. JAMA. 2017.

. 2017 May 23;317(20):2132.

doi: 10.1001/jama.2017.4743.

¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

No abstract available

Comment in

Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply.
Block GA, Chertow GM. Block GA, et al. JAMA. 2017 May 23;317(20):2132-2133. doi: 10.1001/jama.2017.4746. JAMA. 2017. PMID: 28535231 No abstract available.

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM. Block GA, et al. JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468. JAMA. 2017. PMID: 28097356 Clinical Trial.